The Endometrial Receptivity Array (ERA) is an advanced test designed to assess the ideal window for embryo implantation in the uterus. By analyzing the genetic expression of endometrial cells, it helps identify the most receptive time for successful pregnancy. This test is especially useful in improving the chances of IVF success.
The ERA test evaluates the genetic activity of the endometrial lining to determine the best time for embryo transfer. It pinpoints the precise window when the uterus is most receptive, enhancing the likelihood of implantation. By doing so, ERA personalizes embryo transfer timing to the patient’s unique cycle.
Through a small biopsy of the uterine lining, ERA analyzes more than 200 genes. This analysis allows the test to provide an accurate prediction of the optimal time frame for implantation. It is a groundbreaking tool in reproductive medicine, helping overcome unexplained implantation failure.
ERA is especially beneficial for those who have undergone multiple failed IVF cycles. For these individuals, understanding when the endometrium is most receptive can be the key to achieving a successful pregnancy.
The ERA test begins with a biopsy taken from the uterine lining during a specific phase of the menstrual cycle. This sample is then sent to a specialized lab where genetic analysis is conducted. The goal is to identify the endometrial receptivity status.
In the lab, gene expression analysis is performed to assess the activity of genes linked to implantation. The results are compared with a standard receptive pattern. This comparison helps pinpoint if the uterus is receptive, pre-receptive, or post-receptive.
Based on the findings, doctors can recommend the ideal timing for embryo transfer. This personalized approach increases the chances of successful implantation during IVF treatments.
ERA (Endometrial Receptivity Array) is suitable for:
ERA is particularly beneficial for optimizing the chances of a successful implantation by ensuring the endometrium is prepared to receive the embryo.
The benefits of ERA (Endometrial Receptivity Array) include:
ERA offers a personalized approach to fertility treatments, increasing the chances of a successful outcome by ensuring the endometrium is optimally prepared.
The biopsy takes a few minutes, and results are usually available in 2-3 weeks.
Some patients experience mild discomfort during the biopsy, similar to menstrual cramps.
No, ERA requires a mock cycle to properly evaluate the uterine lining.
Coverage varies, so it’s best to check with your provider for specific details